A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma

NCT01171092 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Malignant Lymphoma, Stem Cell Type
Autologous Transplant

Interventions

DRUG: bortezomib and G-CSF

Sponsor

University of Kansas Medical Center

Collaborators

[object Object]